Clinical trial
The Medtronic RESOLUTE Clinical Trial
NCT00248079 · Medtronic Vascular, Industry · Completed
Key facts
| NCT number | NCT00248079 |
|---|---|
| Title | The Medtronic RESOLUTE Clinical Trial |
| Official title | The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions |
| Lead sponsor | Medtronic Vascular, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Coronary Artery Stenting |
| Enrollment | 139 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Oct 1, 2011 |
| First posted | Nov 3, 2005 |
| Last update posted | Oct 20, 2011 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: